Therapeutic Implications of microRNAs in Depressive Disorders: A Review

Int J Mol Sci. 2022 Nov 4;23(21):13530. doi: 10.3390/ijms232113530.

Abstract

MicroRNAs are hidden players in complex psychophysical phenomena such as depression and anxiety related disorders though the activation and deactivation of multiple proteins in signaling cascades. Depression is classified as a mood disorder and described as feelings of sadness, loss, or anger that interfere with a person's everyday activities. In this review, we have focused on exploration of the significant role of miRNAs in depression by affecting associated target proteins (cellular and synaptic) and their signaling pathways which can be controlled by the attachment of miRNAs at transcriptional and translational levels. Moreover, miRNAs have potential role as biomarkers and may help to cure depression through involvement and interactions with multiple pharmacological and physiological therapies. Taken together, miRNAs might be considered as promising novel therapy targets themselves and may interfere with currently available antidepressant treatments.

Keywords: MicroRNA; anxiety; depression; depressive disorder.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Biomarkers
  • Depressive Disorder* / drug therapy
  • Depressive Disorder* / genetics
  • Humans
  • MicroRNAs* / metabolism

Substances

  • MicroRNAs
  • Antidepressive Agents
  • Biomarkers